Results 11 to 20 of about 14,264 (163)
World Medical &Health Policy, Volume 15, Issue 4, Page 414-434, December 2023., 2023 Abstract Cardiovascular disease (CVD) is the leading cause of death among American Indians and Alaska Natives (AIANs). Despite copious research on CVD incidence and outcome discrepancies, a social determinants of health (SDOH) focused framework on CVD risk factors and health outcomes in AIAN populations has not been undertaken.
Eric Leung +3 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 12, Page 1029-1040, December 2023., 2023 Highlights The Blood Pressure Control Target in Diabetes (BPROAD) study is a multicenter, randomized controlled trial conducted in mainland China to test the hypothesis of whether intensive blood pressure (BP) management (systolic BP <120 mm Hg) has additional benefits over standard BP management (systolic BP <140 mm Hg) over a follow‐up period of up ...
The BPROAD Study Group +18 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 12, Page 1070-1080, December 2023., 2023 Highlights Lipid profiles of small extracellular vesicles (sEVs) in patients with diabetes or diabetic cardiovascular disease are rarely reported. n‐3 docosahexaenoic acid (DHA)‐enriched triacylglycerol (TG) was found to decrease in sEVs from serum of patients with diabetic cardiovascular disease (DM‐CAD).
Wei Ding +3 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 11, Page 968-977, November 2023., 2023 Highlights Among 301 studies, diabetes mellitus was the most studied cardiometabolic risk factor. In the network meta‐analysis, cerebrovascular disease had the highest impact (relative risk [RR] 1.69; 95% CI, 1.65–1.73) on COVID‐19 outcomes compared to other cardiometabolic risk factors.
Alina Binbin Li +9 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 11, Page 944-954, November 2023., 2023 Highlights Preclinical data showed that dipeptidyl peptidase‐4 inhibitors (DPP‐4is) may prevent insulin‐induced atherosclerosis. In patients treated with insulin for type 2 diabetes who underwent ≥2 serial coronary computed tomography angiographies(CCTA), a new obstructive coronary artery disease (OCAD) was less developed on the follow‐up CCTA in those
Young Choi +4 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 10, Page 853-865, October 2023., 2023 Highlights Few studies have investigated the association of large‐scale biomarkers and pulse wave velocity (PWV) among diabetic patients. This study investigates the relationships of serum laboratory tests with PWV and explored the associations between PWV and all‐cause mortality among diabetic patients.
Yong‐Qi Liang +9 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 10, Page 881-889, October 2023., 2023 Highlights Serum low‐density lipoprotein cholesterol (LDL‐C) levels were positively and significantly associated with a high risk of incident diabetes. Even in participants with normal LDL‐C levels (<130 mg/dL), a 1‐SD increase in LDL‐C levels was significantly associated with a higher risk of diabetes development.
Jiaojiao Huang +13 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 10, Page 890-899, October 2023., 2023 Highlights Patients with type 2 diabetes (T2D) are prone to developing chronic diabetes‐related complications at the microvascular and macrovascular levels. The Computerized Nailfold Video‐Capillaroscopy (CNVC) provides specific information on both quantitative and qualitative characteristics of microvasculature at the level of fingers.
Giuseppe Lisco, Vincenzo Triggiani
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 10, Page 838-852, October 2023., 2023 Highlights This review outlines the history of miRNA discovery and its major advances in the field of metabolism. We explore the roles of miRNAs in diabetes‐related cognitive impairment. We innovatively propose that miRNAs also act with a certain organ‐targeting specificity due to the organ‐targeting nature of extracellular vesicles, which may aid ...
Yining Chao +5 more
wiley +1 more source
Journal of Diabetes, Volume 15, Issue 8, Page 674-684, August 2023., 2023 Highlights In people with type 2 diabetes, the risk of all‐cause, cardiovascular disease, and cancer mortality increased with higher gamma‐glutamyl transferase (GGT) concentrations. Stronger effects of GGT levels and all‐cause mortality were observed in the group with body mass index <25 kg/m2 and those with dyslipidemia.
Haoyu Guan +12 more
wiley +1 more source